PIO 7706 The potential of perflenapent e
β
JM Correas; O HΓ©lΓ©non; L Menassa; A MΓ©jean; JC Boyer; JF Moreau
π
Article
π
1997
π
Elsevier Science
π
English
β 143 KB
Purpose: To present clinical pharmacology of Sonovue (BRl) a new contrast medium (CM) for ultrasound imaging. Methods: Ninety-eight healthy volunteers in five single-or repeateddose phase I trials (two placebo-controlled). Sonovue doses from 0.003 (single) to 0.6 mlikg bw (cumulative of three consec